Nursing Home Press Releases
Nursing Home Placement Postponed Close to Two Years for Aricept-Treated Alzheimer's Disease Patients
Posted on Tue, May 13, 2008 at 2:43 am
Persistent treatment with ARICEPT (donepezil), the first and only once-a-day medication approved for use in Canada to treat the symptoms of mild to moderate Alzheimer's disease (AD), may delay dementia-related nursing home placement of AD patients for 21 months. Results of a study1 recently presented at the 14th meeting of the American Association of Geriatric Psychiatry showed that persistent treatment with ARICEPT allowed patients to remain at home with their families longer before requiring full-time… Read More.